Table 2.
Database | Pathway | Genes | FDR Value | Proportion |
---|---|---|---|---|
Reactome Pathways | Metabolism of proteins | 660 | 5.03 × 10−52 | 17.75% |
Reactome Pathways | Gene expression (Transcription) | 536 | 1.6 × 10−51 | 14.42% |
Reactome Pathways | Cellular responses to stress | 278 | 1.73 × 10−44 | 7.48% |
Reactome Pathways | Disease | 525 | 3.89 × 10−42 | 14.12% |
Reactome Pathways | Metabolism of RNA | 299 | 1.99 × 10−40 | 8.04% |
WikiPathways | VEGFA-VEGFR2 signaling pathway | 205 | 4.44 × 10−29 | 5.51% |
WikiPathways | Alzheimer’s disease and miRNA effects | 129 | 3.6 × 10−19 | 3.47% |
WikiPathways | DNA IR-damage and cellular response via ATR | 64 | 8.38 × 10−17 | 1.72% |
WikiPathways | Integrated breast cancer pathway | 89 | 1.39 × 10−16 | 2.39% |
WikiPathways | Androgen receptor signaling pathway | 65 | 1.94 × 10−15 | 1.75% |
KEGG Pathways | Shigellosis | 122 | 3.57 × 10−21 | 3.28% |
KEGG Pathways | Amyotrophic lateral sclerosis | 148 | 4.07 × 10−17 | 3.98% |
KEGG Pathways | Viral carcinogenesis | 99 | 6.45 × 10−17 | 2.66% |
KEGG Pathways | Parkinson disease | 110 | 9.04 × 10−15 | 2.96% |
KEGG Pathways | Huntington disease | 125 | 1.41 × 10−14 | 3.36% |